Use this button to switch between dark and light mode.

Share your feedback on this Case Opinion Preview

Thank You For Submiting Feedback!

Experience a New Era in Legal Research with Free Access to Lexis+

  • Case Opinion

Juno Therapeutics, Inc. v. Kite Pharma, Inc.

Juno Therapeutics, Inc. v. Kite Pharma, Inc.

Supreme Court of the United States

November 7, 2022, Decided

No. 21-1566.

Opinion

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.

Read The Full CaseNot a Lexis Advance subscriber? Try it out for free.

Full case includes Shepard's, Headnotes, Legal Analytics from Lex Machina, and more.

2022 U.S. LEXIS 4840 *; 143 S. Ct. 402; 214 L. Ed. 2d 199; 91 U.S.L.W. 3102; 2022 WL 16726060

Juno Therapeutics, Inc., et al., Petitioners v. Kite Pharma, Inc.

Prior History: Juno Therapeutics, Inc. v. Kite Pharma, Inc., 10 F.4th 1330, 2021 U.S. App. LEXIS 25706 (Fed. Cir., Aug. 26, 2021)

Judges:  [*1] Roberts, Thomas, Alito, Sotomayor, Kagan, Gorsuch, Kavanaugh, Barrett, Jackson.